Showing results (11-20 of 248) with videos related to

Sort By:
Pageof 25
Therapeutic Advances in Hematology|April 24, 2013
Novel agents in indolent lymphomasMichele Merli, Andrea Ferrario, Claudia Basilico, et al.
Haematologica|October 2, 2010
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSSChiara Elena, Francesco Passamonti, Elisa Rumi, et al.
Best Practice & Research. Clinical Haematology|February 18, 2018
Overview on the management of non-gastric MALT lymphomasIrene Defrancesco, Luca Arcaini
Current Clinical Pharmacology|February 17, 2010
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomasLuca Arcaini, Raffaele Bruno
International Journal of Molecular Sciences|May 13, 2023
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical FormsSara Fraticelli, Marco Lucioni, Giuseppe Neri, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphomaLuca Arcaini, Marzia Varettoni, Emanuela Boveri, et al.
Therapeutic Advances in Hematology|April 8, 2016
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Barbara Vannata, Luca Arcaini, Emanuele Zucca
Blood|March 19, 2016
Splenic marginal zone lymphoma: from genetics to managementLuca Arcaini, Davide Rossi, Marco Paulli
American Journal of Hematology|December 4, 2009
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomasLuca Arcaini, Michele Merli, Francesco Passamonti, et al.
Ejhaem|November 10, 2025
Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian CohortCaterina Cristinelli, Michele Merli, Marco Lucioni, et al.
Pageof 25